Undertreatment of Patients with Myelodysplastic Syndromes (MDS): Analysis of an Electronic Medical Records (EMR) Database Cohort of US MDS Patients von Steensma, D.P, Scott, B.L, Ma, X, Fliss, A, Kiselev, P, Swern, A.S, Sugrue, M.M

Volltext

Effect of Lenalidomide Exposure on Response and Outcomes in Patients with Lower-Risk Non-Del(5Q) Myelodysplastic Syndromes (MDS) von Garcia-Manero, G, Santini, V, Almeida, A, Fenaux, P, Gattermann, N, Ozawa, K, Goldberg, S.L, Weaver, J, Sugrue, M.M

Volltext

Current Diagnosis Patterns for Acute Myeloid Leukemia: Concordance Between Clinical Practice (Connect® Disease Registry) and Who 2008 Recommendations von George, T.I, Erba, H.P, Pollyea, D.A, Abedi, M, Roboz, G.J, Thompson, M.A, Fliss, A, Swern, A.S, Nifenecker, M, Kiselev, P, Sugrue, M.M, Foucar, K

Volltext

217 DEFINING LIKELIHOOD OF FUTURE RESPONSE IN PATIENTS WITH DEL(5Q) MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH LENALIDOMIDE von Gerds, A.T, List, A.F, Giagounidis, A, Hellström-Lindberg, E, Li, J. Shiansong, Swern, A.S, Sugrue, M.M, Fenaux, P, Sekeres, M.A

Volltext

122 - Undertreatment of Patients with Myelodysplastic Syndromes (MDS): Analysis of an Electronic Medical Records (EMR) Database Cohort of US MDS Patients von Steensma, D.P., Scott, B.L., Ma, X., Fliss, A., Kiselev, P., Swern, A.S., Sugrue, M.M.

Volltext

79 - Effect of Lenalidomide Exposure on Response and Outcomes in Patients with Lower-Risk Non-Del(5Q) Myelodysplastic Syndromes (MDS) von Garcia-Manero, G., Santini, V., Almeida, A., Fenaux, P., Gattermann, N., Ozawa, K., Goldberg, S.L., Weaver, J., Sugrue, M.M.

Volltext

170 - Current Diagnosis Patterns for Acute Myeloid Leukemia: Concordance Between Clinical Practice (Connect® Disease Registry) and Who 2008 Recommendations von George, T.I., Erba, H.P., Pollyea, D.A., Abedi, M., Roboz, G.J., Thompson, M.A., Fliss, A., Swern, A.S., Nifenecker, M., Kiselev, P., Sugrue, M.M., Foucar, K.

Volltext